McKinney Alexander M, Kieffer Stephen A, Paylor Rogerich T, SantaCruz Karen S, Kendi Ayse, Lucato Leandro
Department of Radiology, University of Minnesota Medical Center and Hennepin County Medical Center, 701 Park Ave., Minneapolis, MN 55415, USA.
AJR Am J Roentgenol. 2009 Jul;193(1):192-206. doi: 10.2214/AJR.08.1176.
Toxic leukoencephalopathy may present acutely or subacutely with symmetrically reduced diffusion in the periventricular and supraventricular white matter, hereafter referred to as periventricular white matter. This entity may reverse both on imaging and clinically. However, a gathering together of the heterogeneous causes of this disorder as seen on MRI with diffusion-weighted imaging (DWI) and an analysis of their likelihood to reverse has not yet been performed. Our goals were to gather causes of acute or subacute toxic leukoencephalopathy that can present with reduced diffusion of periventricular white matter in order to promote recognition of this entity, to evaluate whether DWI with apparent diffusion coefficient (ADC) values can predict the extent of chronic FLAIR abnormality (imaging reversibility), and to evaluate whether DWI can predict the clinical outcome (clinical reversibility).
Two neuroradiologists retrospectively reviewed the MRI examinations of 39 patients with acute symptoms and reduced diffusion of periventricular white matter. The reviewers then scored the extent of abnormality on DWI and FLAIR. ADC ratios of affected white matter versus the unaffected periventricular white matter were obtained. Each patient's clinical records were reviewed to determine the cause and clinical outcome. Histology findings were available in three patients. Correlations were calculated between the initial MRI markers and both the clinical course and the follow-up extent on FLAIR using Spearman's correlation coefficient.
Of the initial 39 patients, seven were excluded because of a nontoxic cause (hypoxic-ischemic encephalopathy [HIE] or congenital genetic disorders) or because of technical errors. In the remaining 32 patients, no correlation was noted between any of the initial MRI markers (percentage of ADC reduction, DWI extent, or FLAIR extent) with the clinical outcome. Three patients had histologic correlation. However, moderate correlation was seen between the extent of abnormality on initial FLAIR and the extent on follow-up FLAIR (r = 0.441, p = 0.047). Of the 13 patients who underwent repeat MRI at 21 days or longer, the reduced diffusion resolved in all but one. Significant differences were noted between ADC values in affected white matter versus unaffected periventricular white matter on initial (p < 0.0001) but not on follow-up MRI (p = 0.13), and in affected white matter on initial versus follow-up (p = 0.0014) in those individuals who underwent repeat imaging on the same magnet (n = 9), confirming resolution of the DWI abnormalities.
Acute toxic leukoencephalopathy with reduced diffusion may be clinically reversible and radiologically reversible on DWI, and may also be reversible, but to a lesser degree, on FLAIR MRI. None of the imaging markers measured in this study appears to correlate with clinical outcome, which underscores the necessity for prompt recognition of this entity. Alerting the clinician to this potentially reversible syndrome can facilitate treatment and removal of the offending agent in the early stages.
中毒性白质脑病可急性或亚急性起病,表现为脑室周围和室上白质(以下简称脑室周围白质)弥散对称减低。此病症在影像学和临床上均可逆转。然而,尚未对磁共振成像(MRI)弥散加权成像(DWI)所见的该疾病多种不同病因进行汇总,并分析其逆转的可能性。我们的目标是收集可表现为脑室周围白质弥散减低的急性或亚急性中毒性白质脑病的病因,以促进对该病症的认识,评估具有表观扩散系数(ADC)值的DWI能否预测慢性液体衰减反转恢复序列(FLAIR)异常的程度(影像学可逆性),以及评估DWI能否预测临床结局(临床可逆性)。
两名神经放射科医生回顾性分析了39例有急性症状且脑室周围白质弥散减低患者的MRI检查。然后,两位阅片者对DWI和FLAIR上的异常程度进行评分。获取患侧白质与未受累脑室周围白质的ADC比值。查阅每位患者临床记录以确定病因和临床结局。3例患者有组织学检查结果。使用Spearman相关系数计算初始MRI指标与临床病程以及FLAIR序列随访异常程度之间的相关性。
最初的39例患者中,7例因非中毒性病因(缺氧缺血性脑病[HIE]或先天性遗传疾病)或技术错误被排除。在其余32例患者中,未发现任何初始MRI指标(ADC降低百分比、DWI范围或FLAIR范围)与临床结局之间存在相关性。3例患者有组织学相关性。然而,初始FLAIR序列上的异常程度与随访FLAIR序列上的异常程度之间存在中度相关性(r = 0.441,p = 0.047)。在21天或更长时间后接受复查MRI的13例患者中,除1例患者外,其余患者的弥散减低均消失。在初始MRI上,患侧白质与未受累脑室周围白质的ADC值存在显著差异(p < 0.0001),但在随访MRI上无显著差异(p = 0.13),并且在同一台磁共振仪上接受复查成像的患者(n = 9)中,患侧白质初始与随访的ADC值存在显著差异(p = 0.0014),证实DWI异常已消失。
弥散减低的急性中毒性白质脑病在临床上可能可逆,在DWI上影像学也可能可逆,在FLAIR MRI上也可能可逆,但程度较轻。本研究中测量的任何影像学指标似乎均与临床结局无关,这突出了及时识别该病症的必要性。提醒临床医生注意这种潜在可逆性综合征有助于在早期阶段进行治疗并去除致病因素。